<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244360</url>
  </required_header>
  <id_info>
    <org_study_id>MU Smoliga Resveratrol</org_study_id>
    <secondary_id>2RESMU194218</secondary_id>
    <nct_id>NCT01244360</nct_id>
  </id_info>
  <brief_title>The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance</brief_title>
  <acronym>MUresv</acronym>
  <official_title>The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marywood University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marywood University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of resveratrol on health and human
      performance. The study will evaluate cognitive function and several indicators of physical
      health before and after taking a resveratrol supplement or a placebo for three weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Measurements

        -  blood laboratory parameters

        -  cognitive assessment changes

        -  body composition changes

        -  vascular endothelial response
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular function</measure>
    <time_frame>4 weeks, with option of additional 4 week treatment period</time_frame>
    <description>vascular response to stress will be measured using flow mediated dilation and ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>4 weeks, with optional additional 4 week treatment period</time_frame>
    <description>Body fat percentage will be measured using a DEXA scan.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammation biomarkers</measure>
    <time_frame>4 weeks, with optional additional 4 week treatment period</time_frame>
    <description>Fasting blood draw</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cognitive function</measure>
    <time_frame>4 weeks, with optional additional 4 week treatment period</time_frame>
    <description>cognitive function will be assessed using a validated computer based assessment tool</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Sugar Pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Supplement: resveratrol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>resveratrol</intervention_name>
    <description>Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.</description>
    <arm_group_label>Dietary Supplement: resveratrol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Comparator: Sugar Pill</intervention_name>
    <description>Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.</description>
    <arm_group_label>Sugar Pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women between 45 and 75 years of age

          -  Normal heart rate and Blood pressure

          -  Ability to use personal computer interface

          -  Successful completion of physical activity readiness questionnaire

        Exclusion Criteria:

          -  Cardiovascular disease, uncontrolled hypertension, lung disease

          -  inability to tolerate exercise

          -  have taken grape related supplement in past 12 months

          -  current use of drugs or dietary supplements to enhance exercise performance

          -  allergy to wine, grape juice or grape seed supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Smoliga, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marywood University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Marywood University</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2010</study_first_submitted>
  <study_first_submitted_qc>November 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2010</study_first_posted>
  <last_update_submitted>June 1, 2011</last_update_submitted>
  <last_update_submitted_qc>June 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>JAmes Smoliga, Ph.D.</name_title>
    <organization>Marywood University</organization>
  </responsible_party>
  <keyword>resveratrol</keyword>
  <keyword>insulin</keyword>
  <keyword>inflammation</keyword>
  <keyword>cognition</keyword>
  <keyword>metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Resveratrol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

